Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform
Author:
Funder
Public Health Ontario
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases
Link
http://link.springer.com/content/pdf/10.1186/s12879-019-4237-3.pdf
Reference31 articles.
1. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7:581–96.
2. World Health Oragnization. Control of the leishmaniases. World Health Organ Tech Rep Ser. 2010;949:22–6.
3. Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, Carvalho E, Ephros M, Jeronimo S, Magill A. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the infectious diseases society of America (IDSA) and the American society of tropical medicine and hygiene (ASTMH). Clin Infect Dis. 2016;63(12):e202–64.
4. Ponte-Sucre A, Diaz E, Padron Nieves M (Eds). Drug resistance in Leishmania parasites: consequences, molecular mechanisms and possible treatments. Vienna: Springer-Verlag Wien; 2013. p. 1–459.
5. Chattopadhyay A, Jafurulla M. A novel mechanism for an old drug: amphotericin B in the treatment of visceral leishmaniasis. Biochem Biophys Res Commun. 2011;416(1–2):7–12.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Culture-directed antibiotics in peritoneal dialysis solutions: a systematic review focused on stability and compatibility;Journal of Nephrology;2023-08-07
2. Antileishmanial activity of 5-nitroindazole derivatives;Therapeutic Advances in Infectious Disease;2023-01
3. Target-Based Rational Improvement Strategies and Pitfalls in Leishmania Drug Discovery;Natural Product Based Drug Discovery Against Human Parasites;2023
4. Liposomal amphotericin B—the past;Journal of Antimicrobial Chemotherapy;2022-11-25
5. Imported cases of cutaneous leishmaniasis in Cuba, 2017: role of human movement;Tropical Diseases, Travel Medicine and Vaccines;2022-07-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3